Table 3.
Variables | Cases (17) | Controls (57) | P |
---|---|---|---|
Age (years) | 59.12±6.57 | 56.61±7.21 | 0.202 |
Age at menopause (years) | 49.82±4.28 | 49.00±3.52 | 0.421 |
YSM | 9.24±6.65 | 7.58±6.49 | 0.369 |
Diabetes (%) | |||
Yes | 13 (76.5) | 23 (39) | 0.006** |
No | 4 (23.5) | 36 (61) | |
Hypertension (%) | |||
Yes | 10 (58.8) | 19 (32.2) | 0.047* |
No | 7 (41.2) | 40 (67.8) | |
Obesity (%) | |||
Yes | 14 (82.4) | 27 (45.8) | 0.008** |
No | 3 (17.6) | 32 (54.2) | |
PMC (%) | |||
Regular | 12 (70.6) | 52 (88.1) | 0.126 |
Irregular | 5 (29.4) | 7 (11.9) | |
HRT use (%) | |||
Yes | 0 (0) | 1 (1.7) | 1.00 |
No | 17 (100) | 58 (98.3) | |
Frequency of bleeding (%) | |||
Single | 1 (5.9) | 28 (47.5) | 0.002** |
Recurrent | 16 (94.1) | 31 (52.5) | |
Endometrial thickness (mm) | |||
<10 | 2 (11.8) | 38 (64.4) | <0.001** |
10-25 | 13 (76.5) | 19 (32.2) | |
>25 | 2 (11.8) | 2 (3.4) | |
Mean endometrial thickness | 18.35±7.32 | 9.05±4.25 |
Univariate comparison. **Strongly Significant,*Moderately significant. Patient characteristics showed significant differences were present with regard to diabetes, recurrent vaginal bleeding episodes, presence of hypertension, presence of obesity/overweight, and endometrial thickness. PMC: Past menstrual cycle, HRT: Hormone replacement therapy